Neurogenetic Therapies

Dr. Ashutosh Pareek, Professor at Banasthali Vidyapith with over 15 years of experience in pharmaceutical sciences, holds gold medals for his Master's and Bachelor's degrees in Pharmacy. Dr. Pareek specializes in neuropharmacology and innovative drug delivery systems, focusing on neurodegenerative disorders, cancer, and autoimmune diseases. His research includes developing advanced drug delivery systems for immunomodulators like naringenin. Dr. Pareek leads a research team working on these critical health issues and has published over 45 research papers and authored five technical books. He holds an international formulation patent and has received numerous awards, including the Zee National Achievers Award 2023. His work is funded by national and international agencies such as ICMR, DST-SERB, DBT, the American Association of Pharmaceutical Scientists, and the International Brain Research Organization. He serves as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology and reviews for leading journals by Elsevier, Springer, and Bentham.Arun Kumar Singh has completed his Master of Pharmacy (M. Pharm) in Pharmaceutics from Galgotias University, Greater Noida, India. Currently, he is serving as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University, where he is actively engaged in both teaching and research.His research interests encompass a wide range of emerging and interdisciplinary fields, including nano-formulation, blockchain technology, the Internet of Things (IoT), machine learning, cancer biology, artificial intelligence, big data analytics, and neuroscience. Demonstrating a strong commitment to academic excellence, Mr. Singh has made significant contributions to the scientific community.He has authored one book with IOP Publishing and has contributed five book chapters in the field of big data with the prestigious River Publishers, Denmark. Furthermore, he has published 28 review articles in reputed journals, including two high-impact papers in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. His research work reflects a cumulative impact factor of 95.6, underlining the quality and influence of his scholarly contributions.In addition to journal publications, Mr. Singh has authored and edited 58 books with internationally recognized publishers such as IOP Publishing, Elsevier, CRC Press, and Wiley, demonstrating his broad expertise and dedication to advancing knowledge in pharmaceutical sciences and related areas.Mr. Singh is known for his exceptional research skills, innovative thinking, leadership qualities, effective decision-making, and positive outlook. His diligent work ethic and unwavering commitment to academic and research excellence set him apart as an extraordinary professional in his field.With a passion for driving innovation and fostering interdisciplinary collaboration, Arun Kumar Singh continues to contribute to the growth of pharmaceutical sciences and aims to make a lasting impact in healthcare and technology-driven research.Prof. Anil Chuturgoon is a medical biochemist with a PhD in toxicology and epigenetics. He is a professor and head of medical biochemistry and is currently the dean of research at the College of Health Sciences. He is a B-rated medical scientist by the National Research Foundation of South Africa; he has published over 200 research papers and 12 chapters in books, and he has edited two books and many conference proceedings.He actively researches epigenetic phenomena in toxicology and its implications in human diseases. He is a world expert on mycotoxins and their biological toxicity in humans. He pioneered research on fusariotoxins and epigenetics and their implication in disease. His contribution to Toxicology has been recognised by the CTD curator (NIEHS, USA), where 8 of his manuscripts are included in this database; the database provides manually curated information about chemical–gene/protein interactions, chemical–disease and gene-disease relationships. He has successfully supervised and graduated over 150 Masters and 50 PhD students. He serves as editor of several journals, including Nature: Scientific Reports and Frontiers in Reproductive Health. Dr Aaushi Pareek works as an Assistant Professor at Banasthali Vidyapith, India. Her research focuses on neuropharmacology and developing targeted drug-delivery systems for neurological and inflammatory diseases. As an independent principal investigator, she is deeply committed to advancing the understanding of neurodegenerative diseases through innovative therapeutic approaches. She holds an international formulation patent for developing polyphenol-loaded phytosomes for cancer treatment. She is also a distinguished recipient of international travel grants from the International Society for Neurochemistry (ISN) and the International Brain Research Organization (IBRO). Dr. Bonga Chiliza is an Associate Professor and Head of the Department of Psychiatry at the University of KwaZulu-Natal in Durban, South Africa. He is the Deputy Editor of the South African Journal of Psychiatry and one of the Founding Directors of the Africa Global Mental Health Institute. He completed his medical degree and psychiatry specialization at the University of KwaZulu-Natal and his PhD at Stellenbosch University. His research interests include first-episode psychosis, schizophrenia, psych epidemiology and health services research and medical education. Prof Chiliza has received several awards from South African institutions and research grants from international funding agencies. He has published more than 120 peer-reviewed articles and book chapters. He has also led a number of not-for-profit boards, including the South African YMCA, the South African Society of Psychiatrists, and Harambee Medical Consulting.

• 1. Molecular and Genetic Basis of Nervous System Disorders2. Systems Biology Approaches in the Diagnosis of Neurological Disorders3. Approaches for Gene Therapy and Its Possible Uses in Neurological Disorders4. Genomic DNA-Based Gene Therapy: Recent Developments and Future Directions5. Vector-Mediated Delivery of Transgenes and RNA Interference-Based Gene Silencing Sequences to Oligodendrocytes6. Gene Transfer to Spinal Cord Neurons and Glial Cells through Adeno-Associated Virus Vector7. Gene Therapy Models8. Case Studies Based on Gene Therapies in Treating Neurological Disorders9. Viral Gene Therapy Targets Astrocytes for Alzheimer's Disease10. Lentiviral Gene Delivery of Orexin to Study Its Role in Alzheimer's Disease11. Neurotrophin Gene Therapy for Parkinson's Disease Under Pharmacological Regulation12. An Emerging Target for Parkinson's Disease Symptom and Medication Management: p11 Gene Therapy13. Application of Gene Therapy Employing Stem Cells to Treat Neurological Disorders14. Developing Human-Induced Pluripotent Stem Cells into Purkinje Neurons15. Utilizing Herpes Simplex Virus Mutants as a Therapeutic Intervention for Neurogenic Pain16. A Synopsis of Preclinical and Clinical Trials Concerning Immunotherapy Virotherapy for Astrocytoma17. Nanoparticles in the Treatment of Neurological Disorders18. Success Rates / Failures of Gene Therapy Techniques